Drug Profile
Fluvoxamine extended release - Beijing CoSci Med Tech
Latest Information Update: 10 Dec 2021
Price :
$50
*
At a glance
- Originator Beijing CoSci Med-Tech
- Class Antidepressants; Oximes; Small molecules
- Mechanism of Action Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase Unknown Social phobia
Most Recent Events
- 26 Jul 2016 Investigation in Social phobia in China (PO)